In this editorial the author examines the initiatives taken by Drugs for Neglected Diseases (DNDi) and Medicines Patent Pool (MPP) organizations to improve access to pan-genotypic hepatitis C treatment.
Browsing: Clinical > Outcomes Research
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
In this report, we look at three upcoming clinical studies that will be investigating coccidioidomycosis, its pathogenesis and how treatment for this potentially fatal infection can be improved.
A new meta-analysis has presented findings reporting that regular vitamin D supplementation could drastically lower the risk of acute respiratory infections.
Researchers have created a model to assess the benefits of vaccination on the burden of non-typhoidal salmonella in Mali; the research could inform policy in many countries where there is high risk of these infections.
A study including over 10,000 patients has demonstrated a lower risk of all-cause 30-day mortality when Clostridium difficile infections are treated with vancomycin as opposed to metronidazole.
In this review the authors look into the potential use of pharmacogenomics in predisposing ribavirin-treated hepatitis C patients to anemia.
Researchers have suggested that we are not doing enough to rectify shortcomings in the global response to disease outbreaks. In addition, they state that more progress must be made for the world to effectively cope with future pandemics.
Which countries are most affected by malaria? Take a look at our exclusive infographic to learn more about the key facts and figures in this year’s report.
Could one vaccine dose be as effective as two or three doses at preventing persistent HPV infection in the cervix in young women? This review discusses HPV vaccine coverage and the possibility of a one-dose schedule.